Month: 2026-04. The team delivered a Docker DNS Configuration Enhancement for the hartwigmedical/scripts repository to stabilize container networking by updating the Docker daemon DNS settings. This change, backed by commit af1436602c3dea178983b632f741fadde07edc1b, reduces DNS resolution failures in development and testing environments, improving deployment reliability and reproducibility.

Month: 2025-10 — hartwigmedical/scripts: Developer VM setup automation and SSH reliability for actin-personalization development. Key deliverables: Automated creation and setup of a personalized development VM, including VM provisioning, Git configuration, Docker installation, pre-commit tooling, and data directories for project resources. Patches to SSH config handling to ensure reliable access by validating SSH config file existence and proper personalization VM configuration. Impact: Reduced developer onboarding and environment setup time; improved reliability and consistency of access to the personalization development VM; lower risk of SSH-related workflow interruptions. Technical highlights: Automation scripts for VM creation and configuration, SSH config validation logic, Docker and pre-commit tooling integration, and Git config automation. Notable commits (ACTIN): 2db9ada287277caefe08b8922a41133593838c32 - ACTIN-2557 Add vm creation for personalization (#115); 2aafa016f02c375406782f7833e2889152991286 - ACTIN-2667 Update vm setup script for actin developer vm (#119).

September 2025: Delivered a major data-model overhaul in hartwigmedical/actin to enable SHAP-based explanations for personalized treatment efficacy predictions. Implemented new data structures (PersonalizedTreatmentSummary, ShapDetail, SimilarPatientsSummary), refactored the treatment efficacy prediction data model, and updated JSON serialization, storage, and related plots to support explainability and personalized distributions. Updated test resources and sample data to reflect the new model and ensure robust coverage of the SHAP-enabled workflow. No critical bugs were reported; the month focused on refactoring and test alignment to reduce regression risk while delivering business value. Impact: improved clinician interpretability, more actionable treatment decisions, and a stronger, more maintainable data architecture. Technologies demonstrated: data modeling, SHAP integration, JSON schema evolution, plotting adjustments, and test/resource maintenance.

2025-08 Monthly Summary — ActIn (hartwigmedical/actin). Delivered visual survival analytics and tightened the codebase to support scalable analytics and ongoing maintainability. Key outcomes include a new survival plotting capability that presents survival trajectories as Lets-Plot-based SVGs in reports, across treatments, and integrated into the personalized evidence chapter to replace legacy tabular survival data with interpretable visuals. A series of refactors consolidated plotting logic into a single function and embraced a more functional style, removing unused code paths and stabilizing defaults. The SurvivalPredictionEntry data class, its factory, and related tests were removed, signaling a shift in the internal modeling approach and a cleaner API. Overall impact: improved interpretability for clinical stakeholders, enhanced user experience in reports, reduced technical debt, and a foundation for future analytics features. Technologies/skills demonstrated include Lets-Plot SVG plotting, Python-based functional refactoring, code cleanup, and versioned test maintenance.

July 2025: Focused on data model simplification in hartwigmedical/actin to reduce maintenance overhead and improve reliability of clinical data ingestion curation. Delivered a targeted refactor by removing the unused CurationCategory enum from IngestionResult, aligning the data schema with current workflows and reducing complexity.

June 2025 performance summary for hartwigmedical/actin. Delivered substantive improvements to progression classification logic, enhanced data validation for curation workflows, and extended the data model to support infection comorbidity. The changes, underpinned by expanded test coverage and targeted refactors, improved decision accuracy, data quality, and maintainability, enabling more reliable analytics and better alignment with patient care workflows.